Cancer has been postulated to be a disorder of differentiation. We propose to address the relationship of altered differentiation to multistage carcinogenesis by means of an in vitro cellular transformation system using mouse epidermal cells. Mouse epidermis is readily transplantable in vivo and in vitro and is the system for classical as well as recent developments in the mechanisms of tumor promotion and malignant conversion. Furthermore, epidermal cells exhibit 4 stages of differentiation similar to human epidermal cells, with well characterized morphologic and immunologic markers. Three hypotheses are to be tested: First, that tumor promoters act to permit the clonal expansion of initiated cells defective in sensitivity to differentiation signals, by inducing terminal differentiation in normal cells competent in sensitivty to such signals. To test this, the potency of certain phorbol ester and non-phorbol ester tumor promoters in inducing the differentiation of epidermal clone 271c cells (derived in our laboratory on the basis of normal response to Ca++ as a differentiation signal) will be compared to their effectiveness as tumor promoters as reported in vivo, and measured in vitro using 271c cells in an assay recently reported by us. Secondly, that tumor promoters enhanced benign tumor promotion but not the malignant conversion of epidermal cells. """"""""Initiated"""""""" subclones of 271c cells will be used as targets for certain tumor promoting and mutagenic agent, alone and in mixed culture with normal cells, and after transplantation in vivo to denuded skin sites. Enhancement of transformation will be evaluated based on growth in soft agar and formation of benign or malignant tumors in vivo. Thirdly, that anti-promoting agents sensitize initiated cells to differentiation signals. Capacity of """"""""initiated"""""""" 271c cells to respond to differentiation signals in the presence of retinoids will be examined. The conditions determining the enhancement vs inhibitory effects of retinoic acid on transformation will be approached by studies of the influence of target cell cycle stage and structural modifications of retinoid analogs. The mechanisms of carcinogenesis proposed herein for study at the biologic level will be used as a basis for future studies of epithelial cell transformation at the molecular level. These studies are important for assessing the potential of differentiation-inducing agents in chemoprevention or treatment of human cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA031101-11
Application #
3169467
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1981-07-15
Project End
1993-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
11
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Liu, Y; Kulesz-Martin, M F (2006) Sliding into home: facilitated p53 search for targets by the basic DNA binding domain. Cell Death Differ 13:881-4
Horn, Elizabeth J; Albor, Amador; Liu, Yuangang et al. (2004) RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 25:157-67
Liu, Yuangang; Lagowski, James P; Vanderbeek, Gretchen E et al. (2004) Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain. Cancer Biol Ther 3:1102-8
McAllister, Shane C; Hansen, Scott G; Ruhl, Rebecca A et al. (2004) Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103:3465-73
Knights, Chad D; Liu, Yuangang; Appella, Ettore et al. (2003) Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification. J Biol Chem 278:52890-900
Wang, Zhiping; Liu, Yuangang; Mori, Motomi et al. (2002) Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates. Carcinogenesis 23:635-43
Huang, Hua; Kaku, Shinsuke; Knights, Chad et al. (2002) Repression of transcription and interference with DNA binding of TATA-binding protein by C-terminal alternatively spliced p53. Exp Cell Res 279:248-59
Liu, Y; Asch, H; Kulesz-Martin, M F (2001) Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting. Cancer Res 61:5402-6
Liu, Y; Kulesz-Martin, M (2001) p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis 22:851-60
Davis, T L; Rabinovitz, I; Futscher, B W et al. (2001) Identification of a novel structural variant of the alpha 6 integrin. J Biol Chem 276:26099-106

Showing the most recent 10 out of 28 publications